OK
The material selection platform
Plastics & Elastomers
The material selection platform
Plastics & Elastomers
by SpecialChem
 
Save
Cette page a bien été ajoutée à vos favoris

Makrolon® 2608

Technical Datasheet | Supplied by Covestro
Makrolon® 2608 by Covestro is a medium viscosity polycarbonate (PC) grade. It is suitable for processing by injection molding. It is suitable for ETO and steam sterilization at 121°C. It is recommended for medical devices. Makrolon® 2608 is biocompatible according to ISO 10993-1 test requirements.
REQUEST A SAMPLE ORIGINAL DATASHEET CONTACT SUPPLIER
Makrolon® 2608
Technical Datasheet | Supplied by Covestro
REQUEST A SAMPLE ORIGINAL DATASHEET CONTACT SUPPLIER
Product Type
PC (Polycarbonate) > PC
Physical Form
Granules
Appearance
Natural
Product Status
COMMERCIAL
Geographical Availability
Africa, Asia / Pacific, Central and Eastern Europe, Middle East and Central Asia, North America, South and Central America, Western Europe
Applications/ Recommended for
  • Healthcare / Medical
  • Injection molding - thermoplastics
Labels/Agency Rating
Biocompatible acc. to ISO 10993-1
Key Features
  • Biocompatible
  • Sterilization, Ethylene Oxide
  • Viscosity, Medium

Makrolon® 2608 Properties

Optical Properties

Value & Unit
Test Condition
Test Method
Haze
< 0.8
(At 3 mm, Transparent Materials) 
ISO 14782
Refractive Index
1.586
(Procedure A) 
ISO 489
Transmission, Visible
89 %
(At 1 mm, Clear Transparent Materials) 
ISO 13468-2

Makrolon® 2608 Processing Guidelines

Injection Properties

Value & Unit
Test Condition
Test Method
Injection Velocity
200 mm/s
Melt Temperature
280 - 320 °C
Barrel Rear Temperature
250 - 270 °C
Want to list or
update your products?
Want to report errors or
suggest improvements?
Access Reliable
Product Information

Database of 100008 Plastics & Elastomers,
reviewed and updated daily

Improve your Product
Selection Experience

Open your choices, compare products,
ask for samples, contact suppliers

Keep-up with latest
Technical Solutions

Be inspired and never miss again crucial
innovations with our weekly email updates

Back to Top